Bionime (TPE:4737) Total Liabilities : NT$3,892 Mil (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Bionime Total Liabilities?

Bionime's Total Liabilities for the quarter that ended in Dec. 2024 was NT$3,892 Mil.

Bionime's quarterly Total Liabilities increased from Jun. 2024 (NT$3,528.75 Mil) to Sep. 2024 (NT$3,704.90 Mil) and increased from Sep. 2024 (NT$3,704.90 Mil) to Dec. 2024 (NT$3,892.26 Mil).

Bionime's annual Total Liabilities increased from Dec. 2022 (NT$2,902.53 Mil) to Dec. 2023 (NT$3,307.37 Mil) and increased from Dec. 2023 (NT$3,307.37 Mil) to Dec. 2024 (NT$3,892.26 Mil).

Bionime Total Liabilities Historical Data

The historical data trend for Bionime's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionime Total Liabilities Chart

Bionime Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

2,414.27

2,487.81

2,902.53

3,307.37

3,892.26

Bionime Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															3,307.37	3,401.25	3,528.75	3,704.90	3,892.26

Bionime Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bionime's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2310.998	+	(1579.181	+	2.076
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	3,892

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	5781.271	-	1889.016
	=	3,892

Bionime's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2310.998	+	(1579.181	+	2.076
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	3,892

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	5781.271	-	1889.016
	=	3,892

Bionime Total Liabilities Related Terms

Thank you for viewing the detailed overview of Bionime's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionime Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionime Corp (TPE:4737) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 100, Daqing Street, Section 2, South District, Taichung, TWN, 40242

Website

https://www.bionime.com

Bionime Corp is engaged in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company's products include blood glucose monitoring devices, Lancing devices, Testing Strips, and blood glucose testing chips which are applied in the testing and monitoring of blood glucose density.

Bionime Headlines

No Headlines